» Articles » PMID: 24326988

Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction

Overview
Journal Circulation
Date 2013 Dec 12
PMID 24326988
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is unclear whether gender and racial/ethnic gaps in the use of and patient adherence to β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and statins after acute myocardial infarction have persisted after establishment of the Medicare Part D prescription program.

Methods And Results: This retrospective cohort study used 2007 to 2009 Medicare service claims among Medicare beneficiaries ≥65 years of age who were alive 30 days after an index acute myocardial infarction hospitalization in 2008. Multivariable logistic regression models examined racial/ethnic (white, black, Hispanic, Asian, and other) and gender differences in the use of these therapies in the 30 days after discharge and patient adherence at 12 months after discharge, adjusting for patient baseline sociodemographic and clinical characteristics. Of 85 017 individuals, 55%, 76%, and 61% used angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers, and statins, respectively, within 30 days after discharge. No marked differences in use were found by race/ethnicity, but women were less likely to use angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and β-blockers compared with men. However, at 12 months after discharge, compared with white men, black and Hispanic women had the lowest likelihood (≈30%-36% lower; P<0.05) of being adherent, followed by white, Asian, and other women and black and Hispanic men (≈9%-27% lower; P<0.05). No significant difference was shown between Asian/other men and white men.

Conclusions: Although minorities were initially no less likely to use the therapies after acute myocardial infarction discharge compared with white patients, black and Hispanic patients had significantly lower adherence over 12 months. Strategies to address gender and racial/ethnic gaps in the elderly are needed.

Citing Articles

Abandonment of prescriptions in medically underserved areas: Primary medication non-adherence in community pharmacies in the delta region of the United States.

Li M, Harmon M, Wasson M, Cardosi L, Henson L, Hill H Explor Res Clin Soc Pharm. 2024; 15:100484.

PMID: 39188584 PMC: 11345311. DOI: 10.1016/j.rcsop.2024.100484.


Gender inequalities in secondary prevention of cardiovascular disease: a scoping review.

Lopez Ferreruela I, Obon Azuara B, Malo Fumanal S, Rabanaque Hernandez M, Aguilar-Palacio I Int J Equity Health. 2024; 23(1):146.

PMID: 39044250 PMC: 11264402. DOI: 10.1186/s12939-024-02230-3.


Sex and Racial Disparities in Proportionate Mortality of Premature Myocardial Infarction in the United States: 1999 to 2020.

Gonuguntla K, Badu I, Duhan S, Sandhyavenu H, Chobufo M, Taha A J Am Heart Assoc. 2024; 13(12):e033515.

PMID: 38842272 PMC: 11255752. DOI: 10.1161/JAHA.123.033515.


Prescribing Trends of Renin-Angiotensin System Inhibitors and Mortality among Acute Coronary Syndrome Patients: Insights from the Malaysian National Cardiovascular Disease Registry.

Suki S, Zuhdi A, Yahya A, Adnan W, Zaharan N Saudi J Med Med Sci. 2024; 12(2):145-152.

PMID: 38764563 PMC: 11098274. DOI: 10.4103/sjmms.sjmms_422_23.


Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.

Tsang C, Wang J, Shih Y Medicine (Baltimore). 2024; 103(18):e37935.

PMID: 38701304 PMC: 11062681. DOI: 10.1097/MD.0000000000037935.


References
1.
Lewis W, Peterson E, Cannon C, Super D, LaBresh K, Quealy K . An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program. Arch Intern Med. 2008; 168(16):1813-9. PMC: 3086550. DOI: 10.1001/archinte.168.16.1813. View

2.
Cohen M, Fonarow G, Peterson E, Moscucci M, Dai D, Hernandez A . Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation. 2010; 121(21):2294-301. DOI: 10.1161/CIRCULATIONAHA.109.922286. View

3.
Smith D, Kramer J, Perrin N, Platt R, Roblin D, Lane K . A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008; 168(5):477-83. DOI: 10.1001/archinternmed.2007.132. View

4.
Ho P, Bryson C, Rumsfeld J . Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119(23):3028-35. DOI: 10.1161/CIRCULATIONAHA.108.768986. View

5.
Rasmussen J, Chong A, Alter D . Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297(2):177-86. DOI: 10.1001/jama.297.2.177. View